Your fact-checks will appear here
Comparison of safety profiles among different COVID-19 vaccines
Independent researchers and public-health advocates have repeatedly flagged that raw, participant‑level datasets from several high‑profile COVID‑19 vaccine trials have not been made publicly available...
Requests for "raw patient data" from COVID‑19 vaccine trials have driven years of legal and scholarly pressure: portions of Pfizer’s phase 3 subject‑level datasets and other documents were released in...
Peer‑reviewed, end‑of‑season estimates specifically labeled “2025–26 end‑of‑season” remain limited in the literature, but a systematic NEJM review of studies through July 31, 2025 concluded that ongoi...